An Open-label, Placebo-controlled Phase 1 Study to Evaluate the Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Male Subjects.

Trial Profile

An Open-label, Placebo-controlled Phase 1 Study to Evaluate the Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Apr 2012

At a glance

  • Drugs Linezolid (Primary)
  • Indications Bacterial infections
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 27 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 13 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top